Status:
COMPLETED
Translating Scientific Evidence Into Practice Using Digital Medicine and Electronic Patient Reported Outcomes
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Collaborating Sponsors:
The Cleveland Clinic
Northwestern University
Conditions:
Inflammatory Bowel Disease (IBD)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Delivery of healthcare has been traditionally limited to in-person visits or hospitalizations, while patients spend the majority of their time at home or work. Digital Medicine (e.g. apps, remote moni...
Detailed Description
Delivery of healthcare has been traditionally limited to in-person office visits or hospitalizations, while patients spent the majority of their time at home or work. Digital Medicine (e.g. apps, remo...
Eligibility Criteria
Inclusion
- Patients with confirmed Inflammatory Bowel Disease (IBD) will be enrolled into DTN in stepped-wedge cluster randomized trial
- Age greater than or equal to 18 years
- Ability to speak or understand English or Spanish Language.
Exclusion
- \- Condition or disease that, in the opinion of the investigators, may make it exceedingly difficult for the patient to use DTN, including, but not limited to, advanced dementia.
Key Trial Info
Start Date :
May 14 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 24 2025
Estimated Enrollment :
543 Patients enrolled
Trial Details
Trial ID
NCT04345393
Start Date
May 14 2022
End Date
March 24 2025
Last Update
July 30 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, Davis
Davis, California, United States, 95616
2
RxHealth
Secaucus, New Jersey, United States, 07094
3
Icahn School of Medicine at Mount Sinai
New York, New York, United States, 10029
4
Cleveland Clinic
Cleveland, Ohio, United States, 44195-0001